BI-D1870

Grouped product items
SizePrice Qty
1mg
$50.00
10mg
$295.00
Catalog Number : 5012813

description

BI-D1870 is a cell permeable and highly specific inhibitor of the ribosomal S6 kinases (RSK 1-4). The RSKs are highly conserved Ser/Thr kinases that promote cell proliferation, growth, motility and survival. It is also reported to prevent gamma irradiation-induced apoptosis and to drive the cells to senescence.
product image

Additional Information

Applications:
FA
Synonyms:
CHEMBL573107, GTPL8038, AB0007926, S14-0516, 2-[ AMINO]-7,8-DIHYDRO-5,7-DIMETHYL-8- -6 -PTERIDINONE
Formulation:
Crystalline solid
Chemical Name:
2-(3,5-difluoro-4-hydroxyanilino)-5,7-dimethyl-8-(3-methylbutyl)-7H-pteridin-6-one
Molecular Formula:

C19H23F2N5O2

Molecular Weight:
391.4
CAS Number
501437-28-1
Purity:
≥95%
Storage Conditions:
Product should be kept at -20°C.
References:

Neise, D., Sohn, D., Stefanski, A., Goto, H., Inagaki, M., Wesselborg, S., ... & Jänicke, R. U. (2013). The p90 ribosomal S6 kinase (RSK) inhibitor BI-D1870 prevents gamma irradiation-induced apoptosis and mediates senescence via RSK-and p53-independent accumulation of p21WAF1/CIP1. Cell death & disease4(10), e859.

Nguyen, T. L. (2008). Targeting RSK: an overview of small molecule inhibitors.Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents)8(7), 710-716.

Sapkota, G., Cummings, L., Newell, F., Armstrong, C., Bain, J., Frodin, M., ... & Alessi, D. (2007). BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivo. Biochem. J401, 29-38.

© BioGems International, Inc. All rights reserved.